Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference27 articles.
1. Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19:581–90.
2. Lewis CM, Vassos E. Prospects for using risk scores in polygenic medicine. Genome Med. 2017;9:96.
3. NorthShore University HealthSystem. Prostate Cancer Genetic Risk Score. 2016. https://www.helix.com/products/prostate-cancer-genetic-risk-score (accessed 15 Nov 2019).
4. Multhaup ML, Kita R, Krock B, Eriksson N, Fontanillas P, Aslibekyan S, et al. White Paper 23-19: The science behind 23andMe’s Type 2 Diabetes report. 2019. https://permalinks.23andme.com/pdf/23_19-Type2Diabetes_March2019.pdf
5. Janssens ACJW. Proprietary algorithms for polygenic risk: protecting scientific innovation or hiding the lack of it? Genes. 2019;10:448.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献